Diploma (LON:DPLM) Stock Rating Reaffirmed by Barclays

Diploma (LON:DPLM - Get Free Report)'s stock had its "overweight" rating restated by analysts at Barclays in a report issued on Wednesday, MarketBeat.com reports. They presently have a GBX 4,050 ($50.87) price objective on the stock. Barclays's price target indicates a potential downside of 1.75% from the stock's previous close.

Several other research analysts have also weighed in on the stock. Berenberg Bank increased their price objective on shares of Diploma from GBX 4,400 ($55.26) to GBX 4,700 ($59.03) and gave the stock a "buy" rating in a report on Monday. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and issued a GBX 4,500 ($56.52) price target on shares of Diploma in a report on Tuesday, May 7th. Finally, Shore Capital reaffirmed a "buy" rating on shares of Diploma in a research report on Monday. One research analyst has rated the stock with a sell rating and four have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of GBX 3,950 ($49.61).

Diploma Trading Up 0.9 %

Shares of DPLM stock traded up GBX 36 ($0.45) during mid-day trading on Wednesday, hitting GBX 4,122 ($51.77). 289,407 shares of the company's stock were exchanged, compared to its average volume of 271,392. The stock has a market cap of £5.52 billion, a price-to-earnings ratio of 4,529.67, a PEG ratio of 2.82 and a beta of 0.73. The company has a quick ratio of 0.80, a current ratio of 2.06 and a debt-to-equity ratio of 44.05. Diploma has a fifty-two week low of GBX 2,772.88 ($34.83) and a fifty-two week high of GBX 4,340 ($54.51). The stock has a 50-day simple moving average of GBX 3,589.52 and a two-hundred day simple moving average of GBX 3,417.33.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.